Submit a report

Announcements

Please note that we will be CLOSED to ALL SUBMISSIONS from 1 December 2024 through 12 January 2025 to give our recommenders and reviewers a holiday break.

We are recruiting recommenders (editors) from all research fields!

Your feedback matters! If you have authored or reviewed a Registered Report at Peer Community in Registered Reports, then please take 5 minutes to leave anonymous feedback about your experience, and view community ratings.

330

The labels and models used to describe problematic substance use impact discrete elements of stigma: A Registered Reportuse asterix (*) to get italics
Charlotte R. Pennington, Rebecca L. Monk, Derek Heim, Abi K. Rose, Thomas Gough, Ross Clarke, Graham Knibb, Roshni Patel, Priya Rai, Halimah Ravat, Ramsha Ali, Georgiana Anastasiou, Fatemeh Asgari, Eve Bate, Tara Bourke, Jayme Boyles, Alix Campbell, Nic Fowler, Sian Hester, Charlotte Neil, Beth McIntyre, Ellie Ogilvy, Amie Renouf, Joni Stafford, Katie Toothill, Hin Kok Wong, Andrew JonesPlease use the format "First name initials family name" as in "Marie S. Curie, Niels H. D. Bohr, Albert Einstein, John R. R. Tolkien, Donna T. Strickland"
2023
<p>Objectives: Problematic substance use is one of the most stigmatised health conditions leading research to examine how the labels and models used to describe it influence public stigma. Two recent studies examine whether beliefs in a disease model of addiction influence public stigma but result in equivocal findings – in line with the mixed-blessings model, Kelly et al. (2021) found that whilst the label ‘chronically relapsing brain disease’ reduced blame attribution, it decreased prognostic optimism and increased perceived danger and need for continued care; however, Rundle et al. (2021) conclude absence of evidence. This study isolates the different factors used in these two studies to assess whether health condition (drug use vs. health concern), aetiological label (brain disease vs. problem), and attributional judgement (low vs. high treatment stability) influence public stigma towards problematic substance use. Methods: 1613 participants were assigned randomly to one of eight vignette conditions that manipulated these factors. They completed self-report measures of discrete and general public stigma and an indirect measure of discrimination. Results: Greater social distance, danger, and public stigma but lower blame were ascribed to drug use relative to a health concern. Greater (genetic) blame was reported when drug use was labelled as a ‘chronically relapsing brain disease’ relative to a ‘problem’. Findings for attributional judgement were either inconclusive or statistically equivalent. Discussion: The labels used to describe problematic substance use appear to impact discrete elements of stigma. We suggest that addiction is a functional attribution, which may explain the mixed literature on the impact of aetiological labels on stigma to date.</p>
You should fill this box only if you chose 'All or part of the results presented in this preprint are based on data'. URL must start with http:// or https://
You should fill this box only if you chose 'Scripts were used to obtain or analyze the results'. URL must start with http:// or https://
You should fill this box only if you chose 'Codes have been used in this study'. URL must start with http:// or https://
problematic substance use; addiction; stigma; discrimination; vignettes; models of addiction; brain disease
NonePlease indicate the methods that may require specialised expertise during the peer review process (use a comma to separate various required expertises).
Social sciences
e.g. John Doe john@doe.com
No need for them to be recommenders of PCI Registered Reports. Please do not suggest reviewers for whom there might be a conflict of interest. Reviewers are not allowed to review preprints written by close colleagues (with whom they have published in the last four years, with whom they have received joint funding in the last four years, or with whom they are currently writing a manuscript, or submitting a grant proposal), or by family members, friends, or anyone for whom bias might affect the nature of the review - see the code of conduct
e.g. John Doe john@doe.com
2022-10-21 16:13:49
Zoltan Dienes